The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
暂无分享,去创建一个
A. Gnasso | G. Sesti | F. Andreozzi | M. Federici | M. Cardellini | D. Lauro | R. Lauro | F. Perticone | C. Irace | S. Frontoni | A. Sciacqua | M. A. Marini